Rethinking the Role of Radiation Therapy in the Management of Epithelial Ovarian Cancer

Rethinking the Role of Radiation Therapy in the Management of Epithelial Ovarian Cancer

Radiation has been relegated to a palliative role in the management of epithelial ovarian cancer (EOC). Contemporary radiation techniques, including intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and image-guided radiation therapy, enable conformal treatmen...

Full description

Bibliographic Details
Main Authors:	Geraldine Jacobson, Valerie Galvan-Turner
Format:	Article
Language:	English
Published:	MDPI AG 2020-04-01
Series:	Diagnostics
Subjects:	ovarian cancer radiation therapy stereotactic body radiation (SBRT)
Online Access:	https://www.mdpi.com/2075-4418/10/4/211

Similar Items

Stereotactic body radiation therapy for an octogenarian with pulmonary carcinosarcoma
by: Wei‐Lun Huang, et al.
Published: (2021-05-01)

CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer
by: Michael Waters, et al.
Published: (2024-01-01)

Stereotactic Body Radiation Therapy for the Management of Hepatocellular Carcinoma: Efficacy and Safety
by: Isaure Roquette, et al.
Published: (2022-08-01)

Rectal Radiation Dose and Clinical Outcomes in Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy With and Without Hydrogel
by: Palak Kundu, et al.
Published: (2022-03-01)

Stereotactic Body Radiation Therapy for the Treatment of Locally Recurrent and Oligoprogressive Non-Small Cell Lung Cancer: A Single Institution Experience
by: Leah M. Katz, et al.
Published: (2022-05-01)

Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy
by: Paulina M. Gutkin, et al.
Published: (2023-03-01)

Overcoming Resistance to Immunotherapy in Head and Neck Cancer Using Radiation: A Review
by: Caressa Hui, et al.
Published: (2021-07-01)

Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplant
by: Moore Assaf, et al.
Published: (2020-04-01)

A Phase II Trial of SABR (Stereotactic Ablative Body Radiotherapy) for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life and Disease Control Outcomes with 5-Year Minimum Followup
by: Constantine Anastasios Mantz
Published: (2014-11-01)

Relationship of dose to vascular target volumes and local failure in pancreatic cancer patients undergoing neoadjuvant chemoradiation
by: Bailey Nelson, et al.
Published: (2022-08-01)

Survival and control prognosticators of recurrent gynecological malignancies of the pelvis and para-aortic region treated with stereotactic body radiation therapy (SBRT)
by: Shaakir Hasan, et al.
Published: (2016-11-01)

Stereotactic Body Radiation Therapy (SBRT) for a Patient with a Myocardial Metastasis: A Case Report
by: Aneesh Dhar, et al.
Published: (2021-01-01)

Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy
by: Abhinav V. Reddy, et al.
Published: (2021-12-01)

Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases
by: Theresa Voglhuber, et al.
Published: (2020-06-01)

Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia
by: Berend J. Slotman, et al.
Published: (2022-08-01)

Stereotactic Body Radiation Therapy: A Versatile, Well-Tolerated, and Effective Treatment Option for Extracranial Metastases From Primary Ovarian and Uterine Cancer
by: Nima Aghdam, et al.
Published: (2020-12-01)

Risk factors of local control in adrenal metastases treated by stereotactic body radiation therapy - a systematic review and meta-analysis
by: Xuehong Liao, et al.
Published: (2023-11-01)

MR-guided stereotactic radiation therapy for head and neck cancers
by: He Wang, et al.
Published: (2024-05-01)

Dysuria Following Stereotactic Body Radiation Therapy for Prostate Cancer
by: Einsley-Marie eJanowski, et al.
Published: (2015-07-01)

Rationale for Combing Stereotactic Body Radiation Therapy with Immune Checkpoint Inhibitors in Medically Inoperable Early-Stage Non-Small Cell Lung Cancer
by: Alexander Chi, et al.
Published: (2022-06-01)

Impact of intrafraction motion in pancreatic cancer treatments with MR-guided adaptive radiation therapy
by: Doris N. Rusu, et al.
Published: (2023-12-01)

Effect of Synchronous Versus Sequential Regimens on the Pharmacokinetics and Biodistribution of Regorafenib with Irradiation
by: Tung-Hu Tsai, et al.
Published: (2021-03-01)

Influence of Dexamethasone Premedication on Acute Lung Toxicity in Lung SBRT
by: Fiori Alite, et al.
Published: (2022-02-01)

Oligometastatic Squamous Cell Transformation From Metastatic Prostate Adenocarcinoma Treated With Systemic and Focal Therapy: A Case Report
by: Karen Autio, et al.
Published: (2022-08-01)

Adoption of Biologically Effective Dose of the Non-Target Lung Volume to Predict Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy With Variable Fractionations for Lung Cancer
by: Yuxin Jiao, et al.
Published: (2020-07-01)

Association of baseline self-reported fatigue with overall survival after stereotactic body radiation therapy for localized prostate cancer
by: Rishabh K. Simhal, et al.
Published: (2022-12-01)

Ventricular tachycardia ablation through radiation therapy (VT-ART) consortium: Concept description of an observational multicentric trial via matched pair analysis
by: Francesco Cellini, et al.
Published: (2023-02-01)

Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer
by: Mix M, et al.
Published: (2019-12-01)

Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer
by: Shalini Moningi, et al.
Published: (2022-07-01)

Stereotactic body radiation therapy in stage I inoperable lung cancer: from palliative to curative options
by: Noureddine Boujelbene, et al.
Published: (2013-05-01)

On-line adaptive and real-time intrafraction motion management of spine-SBRT on an MR-linac
by: Justine M. Cunningham, et al.
Published: (2022-08-01)

Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy
by: Matthew D. Hall, et al.
Published: (2023-01-01)

Extreme Hypofractionation with SBRT in Localized Prostate Cancer
by: Maria Antonia Gómez-Aparicio, et al.
Published: (2021-08-01)

Considerations on surgery invasiveness and response and toxicity patterns in classic palliative radiotherapy for acrometastases of the hand: a hint for a potential role of stereotactic body radiation therapy? A case report and literature review
by: Gianluca Ferini, et al.
Published: (2023-06-01)

Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer
by: Lindsey Gallagher, et al.
Published: (2023-10-01)

Bothersome Hematospermia Following Stereotactic Body Radiation Therapy for Prostate Cancer
by: Sarthak Shah, et al.
Published: (2021-11-01)

Long-Term Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy for Recurrent, Previously-Irradiated Head and Neck Cancer
by: Joel Thomas, et al.
Published: (2020-02-01)

Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Early Stage  Non-small Cell Lung Cancer
by: Lu CHEN, et al.
Published: (2014-04-01)

The short-term outcomes of pulmonary metastasectomy or stereotactic body radiation therapy for pulmonary metastasis from epithelial tumors
by: Ryu Kanzaki, et al.
Published: (2020-02-01)

Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy
by: E. Leung, et al.
Published: (2020-01-01)